CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Amazon Biotech, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Amazon Biotech, Inc.
43 West 33rd Street
Suite 405
Phone: (212) 695-3003p:212 695-3003 New York, NY  84107  United States Ticker: AMZO AMZO
This company is no longer actively traded on any major stock exchange.
Business Summary
Amazon Biotech, Inc. is a development-stage company that was established to focus on the research and development of drugs from nature. The Company focuses on the treatment of HIV/AIDS naturally through the use of immune-based therapies. The Company’s HIV/AIDS Drugs consist of Investigational Drugs. These include AMZ0026, AMZ0026-H and AZC0027. These are immunomodulator and anti-viral drug formula. AMZ0026 can be used to treat Lyme disease. The Company is in the Phase I/II study to test the safety and efficacy of its Botanical Drug Product AMZ0026 in pre-symptomatic HIV-positive patients undergoing no other anti-retroviral therapies. AMZ0026's sister-formulation, AMZ0026-H contains an additional anti-viral botanical component. AZC0027 is the Company’s breast-cancer drug formulation.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
10/31/20077/31/2007YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Chaim J.Lieberman 47 1/7/2011 1/1/2010
Chief Financial Officer JeremyWerblowsky 37 1/7/2011 1/7/2011

Business Names
Business Name
AMAZON BIOTECH INC
AMZB
AMZO
ASYST CORP

General Information
Outstanding Shares: 35,279,913 (As of 11/30/2010)
Shareholders: 713
Stock Exchange: OTC
Federal Tax Id: 870416131
Email Address: info@amazonbiotech.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023